Shane Baistrocchi
Shane Baistrocchi
Microbiologist, Research Institute of the McGill University Health Centre
Verified email at
Cited by
Cited by
The fungal exopolysaccharide galactosaminogalactan mediates virulence by enhancing resistance to neutrophil extracellular traps
MJ Lee, H Liu, BM Barker, BD Snarr, FN Gravelat, Q Al Abdallah, ...
PLoS pathogens 11 (10), e1005187, 2015
Microbial glycoside hydrolases as antibiofilm agents with cross-kingdom activity
BD Snarr, P Baker, NC Bamford, Y Sato, H Liu, M Lehoux, FN Gravelat, ...
Proceedings of the National Academy of Sciences 114 (27), 7124-7129, 2017
Posaconazole-loaded leukocytes as a novel treatment strategy targeting invasive pulmonary aspergillosis
SR Baistrocchi, MJ Lee, M Lehoux, B Ralph, BD Snarr, R Robitaille, ...
The Journal of infectious diseases 215 (11), 1734-1741, 2017
Beyond tissue concentrations: antifungal penetration at the site of infection
Y Zhao, B Prideaux, S Baistrocchi, DC Sheppard, DS Perlin
Medical mycology 57 (Supplement_2), S161-S167, 2019
Galectin-3 enhances neutrophil motility and extravasation into the airways during Aspergillus fumigatus infection
BD Snarr, G St-Pierre, B Ralph, M Lehoux, Y Sato, A Rancourt, ...
PLoS pathogens 16 (8), e1008741, 2020
Supervised exercise for cardiovascular rehabilitation—the Limerick programme
R O’Connor, R Power, K Bissett, KA Bourdan, K Togher, H Power, ...
Irish Journal of Medical Science (1971-) 189 (1), 403-404, 2020
In vivo pharmacokinetics and pharmacodynamics of posaconazole in a mouse model of invasive aspergillosis
SR Baistrocchi, H Liu, RJM Bruggeman, WW Hope, S Filler, DC Sheppard
MYCOSES 60, 221-222, 2017
Strategies to Optimize the Effectiveness of Antifungal Treatment for Invasive Aspergillosis
D Sheppard, J Fricker, S Baistrocchi
Anti-Infective Agents 15 (1), 20-24, 2017
The system can't perform the operation now. Try again later.
Articles 1–8